Fagiolini A

Department of Molecular Medicine, School of Medicine, University of Siena, Siena, Italy.

2 preprints · 18 papers · ORCID

PreprintKetamine

Neurite Complexity and Plasticity Markers Track Synaptic Vesicle Density in the Living Human Brain: A Multimodal PET-MRI-EEG Study

Agnorelli C, Peill J, Kurtin DL +25

Europe PMC2026
ArticleKetamine

Profiling intranasal esketamine for adults with major depressive disorder and acute suicidal ideation or behavior: a phenotype-informed drug profile.

Pinzi M, Cuomo A, Rescalli MB +2

Europe PMC2026
ArticleKetamine

Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report.

Young AH, Baune BT, Benatti B +13

Europe PMC2026
ArticleKetamine

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Young AH, Bartova L, Cardoner N +9

Europe PMC2026
ArticleKetamine

The Monoamine-Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry.

Carmellini P, Cuomo A, Rescalli MB +3

Europe PMC2026
ArticleKetamine

Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.

Cuomo A, McIntyre R, Koukouna D +7

Europe PMC2026
ArticleKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Agnorelli C, Peill J, Sawicka G +18

Europe PMC2026
ArticleKetamine

Advances in antidepressant pharmacotherapy: phase 3 evidence and clinical perspectives.

Cuomo A, Pinzi M, Fagiolini A

Europe PMC2026
ArticleKetamine

Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.

Canuso CM, Bossie C, Fu DJ +12

Europe PMC2025
ArticleKetamine

Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD

Young A, Godinov Y, Rive B +8

Europe PMC2025
ArticleKetamine

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial - ERRATUM.

Young AH, Llorca PM, Fagiolini A +9

Europe PMC2025
PreprintKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach

Agnorelli C, Peill J, Sawicka G +16

Europe PMC2025
ArticlePsilocybin

Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.

Agnorelli C, Spriggs M, Godfrey K +8

Europe PMC2025
ArticleKetamine

Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings.

Agnorelli C, Cinti A, Barillà G +12

Europe PMC2025
ArticleKetamine

Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review.

Pardossi S, Fagiolini A, Cuomo A

Europe PMC2024
ArticleKetamine

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial.

Young AH, Llorca PM, Fagiolini A +9

Europe PMC2025
ArticleKetamine

Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression.

McIntyre RS, Bitter I, Buyze J +9

Europe PMC2024
ArticleKetamine

A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?

Pardossi S, Fagiolini A, Scheggi S +1

Europe PMC2024
ArticlePsychedelics

Membrane Permeation of Psychedelic Tryptamines by Dynamic Simulations.

Palmisano VF, Agnorelli C, Fagiolini A +4

Europe PMC2024
ArticleKetamine

Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis.

Rodolico A, Cutrufelli P, Di Francesco A +12

Europe PMC2024